Millennium Management
DNA icon

Millennium Management’s Ginkgo Bioworks DNA Stock Holding History

Millennium Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,500
Closed -$507K – 6255
2023
Q4 		$507K Buy
+7,500
New +$459K ﹤0.01% 4632
2022
Q4 		– Sell
-5,000
Closed -$624K – 6652
2022
Q3 		$624K Buy
+5,000
New +$596K ﹤0.01% 4760

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's DNA Position: Q1 2026 in Review

Millennium Management increased its Ginkgo Bioworks (DNA) stake by 898% in Q1 2026, buying an estimated $3.65M and bringing the position to 487,957 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

Millennium Management first reported a position in DNA in Q3 2021 and has held it in 17 quarters since. The position peaked at $17.5M in Q3 2021. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Millennium Management held 487,957 shares of Ginkgo Bioworks worth $2.99M as of Q1 2026.
  • Millennium Management bought 439,056 Ginkgo Bioworks shares in Q1 2026, an estimated $3.65M.
  • Ginkgo Bioworks made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3466 holding.
  • Millennium Management first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 17 quarters since.
  • Millennium Management's Ginkgo Bioworks position peaked at $17.5M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.